Durect Corp (DRRX) Stock Price, Quote & News

Company Profile

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment of patients with metabolic dysfunction-associated steatohepatitis. The company also offers POSIMIR,...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 408 777 1417

Fax: 408 777 3577

Website: www.durect.com

Address:

10240 Bubb Road, Cupertino, United States

TensorSecurities Aug. 23 at 11:18 AM

$DRRX DURECT Corporation is facing pharmaceutical development challenges and partnership needs

0 · Reply

bnjhnsn Aug. 22 at 1:55 PM

$DRRX r scott Asen is accumulating CVR's

1 · Reply

bnjhnsn Aug. 21 at 6:36 PM

$DRRX excluding any previous losses, if the First sales goal is realized, the CVR pays 20x your investment. If the higher sales goal is reached within 10 years of product selling, then it pays an additional 53x the investment cost. (15 cents) They must really think that this is a long shot.

3 · Reply

Jason_Craps Aug. 21 at 5:09 PM

$DRRX @DMONEY1337 Maybe people are starting to figure out the CVR has value? Slowly, but they are figuring out.

1 · Reply

phillysea12 Aug. 19 at 2:18 AM

$DRRX I am confused. Can someone in plain, concise English ( non- legalize) explain what happens to 800 shares I’m holding of Drrx if I accept their offer? I think I understand that the bonus would also apply but confused on whether I get the cash payout and still hold shares or do my shares go away and somehow if the goal is reached get the bonus payment? Thanks in advance, I’m sure I’m not the only one confused here after reading the messages posted.

2 · Reply

LeRoi_it Aug. 18 at 9:11 PM

$DRRX are you sure there are 31 million shares? 63 million dollars divided by 1.75 gives me 36 millions.. except for that I agree with your reasonement

1 · Reply

bnjhnsn Aug. 18 at 6:41 PM

$DRRX im quite surprised that so many shares are still being traded daily. Being that there are no catalysts on the horizon for the next few years and merge news is old.

1 · Reply

bigbulldaddy Aug. 16 at 6:10 PM

$DRRX so I got a look at the agreement. They were working on this all through end of 2023 and all of 2024 so I feel better about the year of nothing… it even appears they got a better deal than offered. 100 million split between 31 million shareholders at time of first FY 500 million sales = 3.22 per share 250 million split between 31 million shareholders at time of first FY at 1 billion sales = 8.06 per share So if this thing becomes the gem we were promised we each net about $11 a share. Did I read that right? Who knows how long it will take them to actually scale to a billion in sales. Hoping that 500 million for sure happens though.

1 · Reply

KINGSPARTAN Aug. 11 at 7:29 PM

$DRRX well, well, well…I step away for a while and see that DRRX finally worked something out, although in my opinion is a lame deal. I stated I was done and not looking to post anymore but wanted to send some final thoughts. Seems to me they could have just landed the funds or gotten a better deal but suppose Papp could not do any better. Keep in mind this is only a buyout of .175 before the reverse split. Congrats to the longs, I suppose. Just out of curiosity should this not be going to shareholders for a VOTE first??? I would think shareholders would need to approve the buyout. What is going to happen to the rest of the longs who do not sell once the deal is completed?

1 · Reply

brunoq14 Aug. 10 at 7:27 PM

$DRRX There is no reason for DRRX to trade up. Bausch is getting all the shares not sold through a merger with a fully owned entity for no more than 1.75 a share. If you buy and surrender your shares however, you might end up with a piece of a 350 million dollar milestone payment if larsucosterol is a very big success way down the road.

1 · Reply

DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health

Jul 29, 2025, 2:21 PM EDT - 24 days ago

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

BHC

Jul 29, 2025, 7:00 AM EDT - 25 days ago

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

BHC

May 13, 2025, 4:05 PM EDT - 3 months ago

DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update

Mar 26, 2025, 8:04 PM EDT - 5 months ago

DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 4:05 PM EDT - 5 months ago

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 19, 2025, 4:30 PM EDT - 5 months ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

Feb 4, 2025, 7:30 AM EST - 7 months ago

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 28, 2025, 10:09 AM EST - 7 months ago

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence

Nov 25, 2024, 6:00 AM EST - 9 months ago

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million

Nov 13, 2024, 10:17 PM EST - 10 months ago

DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 10 months ago

DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 6, 2024, 4:45 PM EST - 10 months ago

DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update

Oct 17, 2024, 8:30 AM EDT - 11 months ago

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024

Sep 25, 2024, 8:00 AM EDT - 11 months ago

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis

Sep 4, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference

Aug 13, 2024, 8:42 PM EDT - 1 year ago

DURECT Corporation (DRRX) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:01 PM EDT - 1 year ago

DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update

Aug 7, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update

May 21, 2024, 8:00 AM EDT - 1 year ago

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis

May 13, 2024, 9:54 PM EDT - 1 year ago

DURECT Corporation (DRRX) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 1 year ago

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update

May 7, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update

Apr 30, 2024, 7:00 AM EDT - 1 year ago

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis

Mar 27, 2024, 6:07 PM EDT - 1 year ago

DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript

Mar 27, 2024, 4:01 PM EDT - 1 year ago

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 20, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update

Mar 4, 2024, 7:00 AM EST - 1 year ago

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada

Feb 7, 2024, 6:48 PM EST - 1 year ago

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Dec 18, 2023, 7:39 AM EST - 1 year ago

Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)

Nov 13, 2023, 6:50 PM EST - 1 year ago

DURECT Corporation (DRRX) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 1 year ago

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update

Nov 9, 2023, 4:30 PM EST - 1 year ago

DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update

Nov 7, 2023, 4:01 PM EST - 1 year ago

DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality

Sep 7, 2023, 7:00 AM EDT - 2 years ago

DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis

Aug 31, 2023, 4:30 PM EDT - 2 years ago

DURECT Corporation Announces Presentations in Upcoming Investor Conferences

Aug 9, 2023, 8:22 PM EDT - 2 years ago

DURECT Corporation (DRRX) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 4:05 PM EDT - 2 years ago

DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update

Aug 3, 2023, 4:30 PM EDT - 2 years ago

DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update

Jul 20, 2023, 8:00 AM EDT - 2 years ago

DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jun 7, 2023, 6:00 AM EDT - 2 years ago

DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis

May 8, 2023, 10:42 PM EDT - 2 years ago

DURECT Corporation (DRRX) Q1 2023 Earnings Call Transcript

May 8, 2023, 4:05 PM EDT - 2 years ago

DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update

May 1, 2023, 7:03 PM EDT - 2 years ago

DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8

Apr 27, 2023, 5:11 PM EDT - 2 years ago

DURECT Corporation to Host KOL Event on Alcohol-Associated Hepatitis

Apr 25, 2023, 6:45 PM EDT - 2 years ago

DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

Apr 10, 2023, 6:00 AM EDT - 2 years ago

DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated Hepatitis

Mar 21, 2023, 4:30 PM EDT - 2 years ago

DURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board

TensorSecurities Aug. 23 at 11:18 AM

$DRRX DURECT Corporation is facing pharmaceutical development challenges and partnership needs

0 · Reply

bnjhnsn Aug. 22 at 1:55 PM

$DRRX r scott Asen is accumulating CVR's

1 · Reply

bnjhnsn Aug. 21 at 6:36 PM

3 · Reply

Jason_Craps Aug. 21 at 5:09 PM

$DRRX @DMONEY1337 Maybe people are starting to figure out the CVR has value? Slowly, but they are figuring out.

1 · Reply

phillysea12 Aug. 19 at 2:18 AM

2 · Reply

LeRoi_it Aug. 18 at 9:11 PM

$DRRX are you sure there are 31 million shares? 63 million dollars divided by 1.75 gives me 36 millions.. except for that I agree with your reasonement

1 · Reply

bnjhnsn Aug. 18 at 6:41 PM

$DRRX im quite surprised that so many shares are still being traded daily. Being that there are no catalysts on the horizon for the next few years and merge news is old.

1 · Reply

bigbulldaddy Aug. 16 at 6:10 PM

1 · Reply

KINGSPARTAN Aug. 11 at 7:29 PM

1 · Reply

brunoq14 Aug. 10 at 7:27 PM

1 · Reply

bnjhnsn Aug. 5 at 1:16 PM

$DRRX im pretty sure that they still have to announce earnings and host a conference call for Q2.

1 · Reply

BernieLomaxxx Aug. 2 at 6:24 PM

$DRRX should be a nice Monday!!

1 · Reply

Wickster_ Aug. 2 at 12:43 PM

$GYRO in such a good for more spike up, watchlist: $VAPE $ELWS $DRRX $REPL -

0 · Reply

Joby099 Aug. 2 at 1:38 AM

$DRRX

0 · Reply

Godwins26 Aug. 1 at 3:26 PM

$DRRX another one $ATCH

0 · Reply

kdsyy Aug. 1 at 2:20 PM

$DRRX This wave of growth is like riding a rocket 🚀, it is really unexpected! I have to say that those who can catch it in advance have a great vision. For example, I

1 · Reply

XtremeBullz Aug. 1 at 6:25 AM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watchlist: $VWAV $DRRX $VAPE $MCVT $CELC

0 · Reply

Joby099 Aug. 1 at 1:15 AM

$DRRX

0 · Reply

Travelling Jul. 31 at 5:10 PM

$NEGG OK sold the last. I shall watch closely for dips. Also watching $AACG $SMX $DRRX $SNDL

1 · Reply

Drrxgernbcrx Jul. 31 at 12:33 AM

$DRRX I wish I could read and understand legal language better. Is the 8k saying 50% of stockholder must accept the 1.75 proposal for it go go thru OR that more than 50% must take no action AGAINST the offer

2 · Reply

davis8uni Jul. 30 at 10:15 PM

$DRRX I like the explanation of catalysts here. He is killing it. Must watch! https://www.youtube.com/watch?v=ZeJ3k2WD3Sw

1 · Reply

Godwins26 Jul. 30 at 8:16 PM

I'm watching these 2 closely $DRRX this has been holding gains for a while stronger bulls holding this 😊 $REPL keep up the good work 😁

0 · Reply

Market Cap	59.00M
Revenue (ttm)	2.03M
Net Income (ttm)	-8.32M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-409.85%
Debt to Equity Ratio	0.00

Volume	417,600
Avg Vol	1,286,778
Day's Range	N/A - N/A
Shares Out	31.05M
Stochastic %K	80%
Beta	0.83
Analysts	Hold
Price Target	$2.50